New insights regarding the potential of the pronucleotide approach in antiviral chemotherapy

Acta Biochimica Polonica

Volumn 43, Issue 1, 1996, Pages 195-208

  Gosselin, Gilles ^a   Girardet, Jean Luc ^a   Périgaud, Christian ^a   Benzaria, Samira ^a   Lefebvre, Isabelle ^a   Schlienger, Nathalie ^a   Pompon, Alain ^a   Imbach, Jean Louis ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

Antiviral activities; Nucleoside analogues; Nucleotide prodrugs; S acyl 2 thioethyl phosphate protecting groups

Indexed keywords

ANIMALIA;

ACICLOVIR; ANTIVIRUS AGENT; DRUG DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; NUCLEOTIDE; PRODRUG; ZIDOVUDINE;

ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; DRUG DESIGN; HUMAN; METABOLISM; REVIEW; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; DRUG DESIGN; HUMANS; INDICATORS AND REAGENTS; MODELS, BIOLOGICAL; NUCLEOTIDES; PRODRUGS; STRUCTURE-ACTIVITY RELATIONSHIP; ZIDOVUDINE;

EID: 0003149806     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.1996_4553     Document Type: Article

References (31)

1. Périgaud, C., Gosselin, G. & Imbach, J.-L. (1992) Nucleoside analogues as chemotherapeutic agents: a review. Nucleosides & Nucleotides 11, 903-945.
2. Kinchington, D. & Golfdthorpe, S. (1995) Current antiviral agents. Part 1 - Herpes viruses, hepatitis viruses and respiratory viruses. Int. Antiviral News 3, 57-61.
3. Goldthorpe, S., Kinchington, D. & Lovelidge, L. (1995) Current antiviral agents. Part 2 - Human immunodeficiency viruses. Int. Antiviral News 3, 92-98.
4. Sommadossi, J.-P. (1993) Nucleoside analogs: similarities and differences. Clin. Infec. Dis. 16 (Suppl 1), S7-S15.
5. Zelphati, O., Degols, G., Loughrey, H., Leserman, L., Pompon, A., Puech, F., Maggio, A.-F., Imbach, J.-L. & Gosselin, G. (1993) Inhibition of HIV-1 replication in cultured cells with phosphorylatcd dideoxyuridine derivatives encapsulated in immunoliposomes. Antiviral Res. 21, 181-195.
6. Alexander, P. & Holy, A. (1994) Prodrugs of analogs of nucleic acid components. Collect. Czech. Chem. Commun. 59, 2127-2165.
7. Jones, R.J. & Bischofberger, N. (1995) Minireview: nucleotide prodrugs. Antiviral Res. 27, 1-17.
8. Périgaud, C., Girardet, J.-L., Gosselin, G. & Imbach, J.-L. (1995) Comments on nucleotide delivery forms; in Advances in Antiviral Drug Design (De Clercq, E. ed.) vol. 2, pp. 142-172.
9. Farquhar, D., Khan, S., Srivastva, D.N. & Saunders, P.P. (1994) Synthesis and antitumor evaluation of bis[(pivaloyloxy)metliyl] 2′-deoxy-5-fluorouridine 5′-monophosphate (FdUMP): A strategy to introduce nucleotides into cells. J. Med. Chem. 37, 3902-3909, and references cited therein.
10. Pompon, A., Lefebvre, I., Imbach, J.-L., Kahn, S. & Farquhar, D. (1994) Decomposition pathways of the mono- and bis(pivaloyloxymethyl) esters of azidothymidine 5-monophosphate in cell extract and in tissue culture medium: an application of the "on-line ISRP-cleaning" HPLC technique. Antiviral Chem. Chemother. 5, 91-98.
11. Périgaud, C., Gosselin, G., Lefebvre, I., Girardet, J.-L., Benzaria, S., Barber, I. & Imbach, J.-L. (1993) Rational design for cytosolic delivery of nucleoside monophosphates: "SATE" and "DTE" as enzyme-labile transient phosphate protecting groups. Bioorg. Med. Chem. Lett. 3, 2521-2526.
12. Sastry, K.J., Nehete, P.N., Khan, S., Plunkett, W., Arlinghaus, R.B. & Farquhar, D. (1992) A new strategy for the chemotherapy of acquired immunodeficiency syndrome: membrane permeable dideoxyuridine monophosphate analogues as potent inhibitors of human immunodeficiency virus infection. Mol. Pharmacol. 41, 441-445.
13. Gosselin, G. & Imbach, J.-L. (1993) The anti-HIV nucleoside phosphotriester approach: controversial comments and complementary data. Int. Antiviral News 1, 100-102.
14. Puech, F., Gosselin, G., Lefebvre, I., Pompon, A., Aubertin, A.-M., Kirn, A. & Imbach, J.-L. (1993) Intracellular delivery of nucleoside monophosphates through a reductase-mediated activation process. Antiviral Res. 22, 155-174.
15. Lefebvre, I., Périgaud, C., Pompon, A., Aubertin, A.-M., Girardet, J.-L., Kirn, A., Gosselin, G. & Imbach, J.-L. (1995) Mononucleoside phosphotriester derivatives with S-acyl-2-thioethyl bioreversible phosphate-protecting groups: intracellular delivery of 3′-azido-2′,3′-dideoxythymidine 5′-monophosphate. J. Med. Chem. 38, 3941-3950.
16. Starrett, J.E., Jr., Tortolani, D.R., Hitchcock, M.J.M., Martin, J.C. & Mansuri, M.M. (1992) Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine. Antiviral Res. 19, 267-273.
17. Srinivas, R.V., Robbins, B.L, Connelly, M.C., Gong, Y.-F., Bischofberger, N. & Friedland, A. (1993) Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonates. Antimicrob. Agents Chemother. 37, 2247-2250.
18. Srinivas, R.V., Robbins, B.L., Connelly, M.C., Gong, Y.-F., Bischofberger, N. & Friedland, A. (1994) Pivaloyloxymethyl esters of acyclic nucleoside phosphonates. Int. Antiviral News 2, 53-55.
19. Starrett, J.E., Jr., Tortolani, D.R., Russell, J., Hitchcock, M.J.M., Whiterock, V, Martin, J.C. & Mansuri, M.M. (1994) Synthesis, oral bioavailability determination, and in vitro evaluation of prodrugs of the antiviral agent 9-[2-(phosphonylmethoxy)ethyl]adenine (PMEA). J. Med. Chem. 37, 1857-1864.
20. Cundy, K.C., Fishback, J.A., Shaw, J.-P., Lee, M.L., Soike, K.F., Visor, G.C. & Lee, W.A. (1994) Oral bioavailability of the antiretroviral agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) from three formulations of the prodrug bis(pivaloyloxymethyl)-PMEA in fasted male cynomolgus monkeys. Pharmaceut. Res. 11, 839-843.
21. Riddler, S.A., Anderson, R.E. & Mellors, J.W. (1995) Antiretroviral activity of stavudine (2′,3′-didehydro-3-deoxythymidine, D4T). Antiviral Res. 27, 189-203.
22. Girardet, J.-L., Périgaud, C., Aubertin, A.-M., Gosselin, G., Kirn, A. & Imbach, J.-L. (1995) Increase of the anti-HIV activity of D4T in human T-cell cultures by the use of the SATE pronucleotide approach. Bioorg. Med. Chem. Lett. 5, 2981-2984.
23. Johnson, M.A., Ahluwalia, G., Connelly, M.C., Cooney, D.A., Broder, S., Johns, D.G. & Fridland, A. (1988) Metabolic pathways for the activation of the antiretroviral agent 2′,3′-dideoxyadenosine in human lymphoid cells. J. Biol. Chem. 263, 15354-15357.
24. Faulds, D. & Brogden, R.N. (1992) Didanosine. Drugs 44, 94-116.
25. Nair, V. & Sells, T.B. (1992) Interpretation of the roles of adenylosuccinate Iyase and of AMP deaminase in the anti-HIV activity of 2′,3′-dideoxyadenosine and 2′,3′-dideoxyinosine. Biochim. Biophys. Acta 1119, 201-204.
26. Benzaria, S., Girardet, J.-L., Périgaud, C., Aubertin, A.-M., Pélicano, H., Maury, G., Gosselin, G., Kirn, A. & Imbach, J.-L. (1994) The SATE pronucleotide derivative of dd A: a more potent HIV inhibitor than AZT. Nucleic Acids Symp. Series 31, 129-130.
27. Périgaud, C., Aubertin, A.-M., Benzaria, S., Pélicano, H., Girardet, J.-L., Maury, G., Gosselin, G., Kirn, A. & Imbach, J.-L. (1994) Equal inhibition of the replication of human immunodeficiency virus in human T-cell culture by ddA bis(SATE)phosphotriester and 3′-azido-2′,3′-dideoxythymidine. Biochem. Pharmacol. 48, 11-14.
28. Baker, D.A. (ed.) (1990) Acyclovir for herpesvirus infectious therapy. Dekker Publications, New York.
29. Wagstaff, A.J., Faulds, D. & Goa, K.L. (1994) Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 47, 153-205.
30. Martin, J.C., McGee, D.P.C., Jeffrey, G.A., Hobbs, D.W., Smee, D.F., Matthews, T.R. & Verheyden, J.P.H. (1986) Synthesis and anti-herpes-virus activity of acyclic 2′-deoxyguanosine analogues related to 9-[(1,3-dihydroxy-2-propoxy)methyllguanine. J. Med. Chem. 29, 1384-1389.
31. Wu, S., Liu, X., Solorzano, M.M., Kwock, R. & Avramis, V.I. (1995) Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5′ end of human TK gene. J. Acquired Immune-Defic. Syndromes Hum. Retrovirol. 8, 1-9.